Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells

Area of Science:

• Immunology
• Virology
• Cellular Biology

Background:

• Conventional methods for studying Epstein-Barr virus (EBV)-induced cytotoxic T-lymphocyte (CTL) memory have limitations.
• In vitro stimulation with lymphoblastoid cell lines (LCLs) fails to assess memory to lytic cycle antigens and overemphasizes dominant latent antigen reactivities.

Purpose of the Study:

• To develop and validate an alternative method for probing the CTL repertoire against EBV.
• To investigate EBV-specific CTL memory responses to both latent and lytic cycle antigens.
• To explore the potential of targeting EBV-positive malignancies using expanded CTL lines.

Main Methods:

• Developed a novel in vitro stimulation approach using epitope peptide-loaded dendritic cells (DCs).
• This DC-based stimulation method was compared to peptide-alone stimulation for efficiency.
• Assessed CTL memory responses in virus carriers to both lytic and latent EBV antigens.

Main Results:

• DC stimulation proved significantly more efficient than peptide-alone stimulation for probing CTL responses.
• Reactivations of both immunodominant and subdominant lytic cycle epitopes were detected in CTL memory of EBV carriers.
• Subdominant latent cycle reactivities to epitopes in latent membrane protein 2 (LMP2) were successfully reactivated and expanded by DC stimulation.

Conclusions:

• The DC-based stimulation method allows for comprehensive analysis of EBV-specific CTL memory, including subdominant reactivities.
• The detection of lytic cycle epitope reactivities suggests ongoing T-cell control of chronic EBV replication.
• Expanded polyclonal CTL lines targeting LMP2 epitopes hold promise for treating EBV-associated cancers.